PRELID1
PRELI domain-containing protein 1, mitochondrial
Also known as: CGI-106, PRELI, PRLD1_HUMAN, PX19
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y255
- Gene
- PRELID1
- Ensembl
- ENSG00000169230
- Chromosome
- 5
- Canonical length
- 219 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
This gene encodes a member of the late embryogenesis abundant motif-containing protein family. The encoded protein is localized to mitochondria and may function as a cytoprotectant by regulating cell death and differentiation. Alternative splicing results in multiple transcript variants encoding different isoforms. Several related pseudogenes have been identified. [provided by RefSeq, Nov 2012]
Canonical amino-acid sequenceUniProt
219 residues, UniProt reviewed canonical sequence.
>Q9Y255|PRELID1
1 MVKYFLGQSV LRSSWDQVFA AFWQRYPNPY SKHVLTEDIV HREVTPDQKL LSRRLLTKTN
61 RMPRWAERLF PANVAHSVYV LEDSIVDPQN QTMTTFTWNI NHARLMVVEE RCVYCVNSDN
121 SGWTEIRREA WVSSSLFGVS RAVQEFGLAR FKSNVTKTMK GFEYILAKLQ GEAPSKTLVE
181 TAKEAKEKAK ETALAATEKA KDLASKAATK KQQQQQQFVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRELID1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 263 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 263 nTPM
- liver: 190 nTPM
- esophagus: 151 nTPM
- kidney: 145 nTPM
- colon: 124 nTPM
- small intestine: 123 nTPM
Single-cell type
- esophageal apical cells: 1,032 nCPM
- syncytiotrophoblasts: 1,029 nCPM
- cytotrophoblasts: 890 nCPM
- esophageal suprabasal cells: 731 nCPM
- migrating cytotrophoblasts: 706 nCPM
- enterocytes: 621 nCPM
Immune cell
- eosinophil: 1,200 nTPM
- non-classical monocyte: 994 nTPM
- intermediate monocyte: 988 nTPM
- myeloid DC: 775 nTPM
- classical monocyte: 765 nTPM
- total PBMC: 613 nTPM
Brain region
- thalamus: 49 nTPM
- spinal cord: 43 nTPM
- pons: 42 nTPM
- midbrain: 41 nTPM
- hypothalamus: 40 nTPM
- choroid plexus: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0.12
- gnomAD missense Z
- 1.26
- DepMap mean gene effect
- -2.5
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- intermembrane lipid transfer
- negative regulation of apoptotic process
- negative regulation of mitochondrial membrane potential
- negative regulation of release of cytochrome c from mitochondria
- phospholipid transport
- positive regulation of cellular respiration
- positive regulation of endopeptidase activity
- positive regulation of phospholipid transport
- positive regulation of T cell apoptotic process
- regulation of membrane lipid distribution
- regulation of mitochondrial membrane potential
- regulation of T cell differentiation
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRELID1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRELID1 as an antibody target. Whether an autoantibody or antibody against PRELID1 could matter depends on whether native PRELID1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRELID1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRELID1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...